Mr Yang Chen

Mayo Clinic, Rochester (United States of America)

Follow

Contributor content

Cardioprotective effects of a novel designer C-type natriuretic peptide-based therapeutic, C53 , for the prevention of post-myocardial infarction heart failure

Presentation

Cardioprotective effects of a novel designer C-type natriuretic peptide-based therapeutic, C53 , for the prevention of post-myocardial infarction heart failure

ESC 365 is supported by

novartis

Explore sponsored resources